Apart from pancreatic adenocarcinoma, prostate adenocarcinoma and thyroid carcinoma, we found a significant upregulation of RECQL4 expression in tumours from 18 out of 21 cancer entities (Figure 5A, p < .01). Here, RECQL4 is linked to prostate adenocarcinoma.